GlaxoSmithKline has appointed Andrew Witty to replace Chief Executive Officer Jean-Pierre Garnier when he retires in May.
Witty, 43, heads the European pharmaceuticals unit of the London-based company and was picked from three internal candidates, Glaxo said in a Regulatory News Service statement today.
Witty, who took over as head of European drug operations in January 2003, was picked over candidates including Chris Viehbacher, head of Glaxo's U.S. unit, and Chief Operating Officer David Stout, analysts said.
Witty, a graduate of Nottingham University, joined Glaxo in 1985 in the U.K., where he held positions as director of pharmacy and distribution and international product manager. He also served as executive in South Africa, the U.S. and Asia.
No comments:
Post a Comment